Immunohistochemical staining for glutathione S-transferase predicts response to platinum-based chemotherapy in head and neck cancer

Clinical Cancer Research

Volumn 2, Issue 11, 1996, Pages 1859-1865

  Nishimura, Toshiro ^b,c   Newkirk, Kenneth ^b   Sessions, Roy B ^b   Andrews, Paul A ^d   Trock, Bruce J ^a   Rasmussen, Audrey A ^a   Montgomery, Elizabeth A ^b   Bischoff, Elizabeth K ^a   Cullen, Kevin J ^a,e  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KANAZAWA UNIVERSITY   (Japan)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ANTINEOPLASTIC AGENTS; CISPLATIN; FEMALE; GLUTATHIONE TRANSFERASE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 0029826295     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics 1995 CA Cancer J. Clin., 45: 8-20, 1995.
2. Jacobs, C., Lyman, G., Velez-Garcia, E., Sridhar, K. S., Knight, W., Hochster, H., Goodnough, L. T., Mortimer, J. E , Einhorn, L. H., and Schactcr, L. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin. Oncol., 10: 257-263, 1992.
3. Wheeler, R. H. Chemotherapy of patients with recurrent head and neck cancers. In: C. Jacobs (ed.), Carcinomas of the Head and Neck: Evaluation, Management, pp. 171-193. Boston: Kluwer Academic, 1990.
4. Kish, J. A., Weaver, A., Jacobs, J., Cummings, G., and Al-Sarraf, M. Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer (Phila.), 53: 1819-1824, 1984.
5. Hong, W. K., Shapshay, S. M., Bhutani, R., Craft, M. L., Ucmakli, A., Yamaguchi, K. T., Vaughan, C. W., and Strong, M. S. Induction chemotherapy in advanced squamous head and neck carcinoma with high-dose cisplatinum and bleomycin infusion. Cancer (Phila.), 44: 19-25, 1979.
6. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation in patients with advanced laryngeal cancer. N. Engl. J. Med., 324: 1685-1690, 1991.
7. Jacobs, C., Goffinet, D. R., Goffinet, L., Kohler, M., and Fee, W. E. Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the Northern California Oncology Group. Cancer (Phila.), 60: 1178-1183, 1987.
8. Hong, W. K., Lippman, S. M., and Wolf, G. T. Recent advances in head and neck cancer: larynx preservation and cancer chemoprevention. Cancer Res , 53: 5113-5120, 1993.
9. Kish, J., Drelichman, A., Jacobs, J., Hoschner, J., Kinzie, J., Loh, J., Weaver, A., and Al-Sarraf, M. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck Cancer Treat. Rep., 66: 471-474, 1982
10. Andrews, P. A. Mechanisms of acquired resistance to cisplatin Cancer Treat. Res., 73: 217-248, 1994.
11. Meister, A. On the discovery of glutathione. Trends Biochem. Sci., 13: 185-188, 1988.
12. Mistry, P., and Harrap, K R. Historical aspects of glutathione and cancer chemotherapy. Pharmacol. & Ther, 49: 125-132, 1991.
13. Meister, A. Glutathione, ascorbate, and cellular protection. Cancer Res., 54 (Suppl.): 1969s-1975s, 1994.
14. Tew, K. D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res., 54: 4313-4320, 1994.
15. Mannervik, B. The enzymes of glutathione metabolism: an overview. Biochem. Soc. Trans., 15, 717-718, 1987.
16. Schecler, R. L., and Alaoui-Jamali, M. A. Glutathione S-transferase in chemotherapy resistance and carcinogenesis. Biochem. Cell Biol., 70: 349-353, 1992.
17. Mulder, T. P., Manni, J. J., Roelofs, H. M., Peters, W. H., and Wiersma, A. Glutathione S-transferases and glutathione in human head and neck cancer Carcinogenesis (Lond.), 16: 619-624, 1995.
18. Dirven, H. A., van Omen, B , and van Bladeren, P. J Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione. Cancer Res., 54: 6215-6220, 1994.
19. Dirven, H. A., Dictus, E. L., Broeders, N. L., van Omen, B., and van Bladeren, P. J. The role of human glutathione S-transferase isoenzymes in the formation of glutathione conjugates of the alkylating cytostatic drug thiotepa. Cancer Res., 55: 1701-1706, 1995.
20. Tew, K. D., Houghton, P. J., and Houghton, J. A. Preclinical and Clinical Modulation of Anticanccr Drugs, pp. 1-79. Boca Raton, FL: CRC Press, 1993.
21. Toffoli, G., Viel, A., Tumiotto, L., Giannini, F. Volpe, R , and Quaia, M. Expression of glutathione S-transferase π in human tumors. Eur. J. Cancer , 28: 1441-1446, 1992
22. Britten, R. A., Green, J. A., and Warenius, H. M. Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents. Int. J Radiat. Oncol. Biol. Phys., 24: 527-531, 1992.
23. Cairns, J., Wright, C., Cattan, A. R., Hall, A. G., Cantwell, B. J., Harris, A. L., and Horne, C. H. Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomas. J. Pathol., 166: 19-25, 1992.
24. Suzuki, T., Johnston, P. N , and Board, P. G. Structure and organization of the human α class glutathione S-transferase genes and related pseudogenes. Genomics. 18: 680-686, 1993
25. Board, P. G., Webb, G. C., and Coggan, M. Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome hands 11q13 and 12q13-14. Ann. Hum. Genet., 53: 205-213, 1989.
26. Ross, V. L., Board, P. G., and Webb, G. C. Chromosomal mapping of the human Mu class glutathione S-transferases to 1p13. Genomics, 18: 87-91, 1993.
27. Tan, K. L., Webb, G. C., Baker, R. T., and Board, P. G. Molecular cloning of a cDNA and chromosomal localization of a human theta-class glutathione S-transferase gene (GSTT2) to chromosome 22. Genomics, 25: 381-387, 1995.
28. Schipper, D L., Verspaget, H. W., Mulder, T. P. J., Sier, C F. M., Ganesh, S., Roelofs, H. M. J., and Peter, W. H. M. Correlation of glutathione S-transferase with overall survival in patients with gastric carcinoma. Proc. Am. Assoc. Cancer Res., 37: 192, 1996.
29. Merritt, W D., Weissler, M. C., Turk, B. F., and Gilmer, T M. Oncogene amplification in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head. Neck. Surg., 116: 1394-1398, 1990.
30. Berenson, J. R., Yang, J., and Mickel, R. A. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas Oncogene, 4: 1111-1116, 1989.
31. Meredith, S. D., Levine, P. A., Burns, J A., Gaffey, M. J., Boyd, J. C., Weiss, L. M., Erickson, N. L., and Williams, M. E. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. Arch. Otolaryngol. Head. Neck. Surg., 121: 790-794, 1995.
32. Gaffey, M. J., Iezzoni, J. C., Meredith, S. D , Boyd, J. C., Stoler, M. H , Weiss, L. M., Zukerberg, L R., Levine, P. A., Arnold, A., and Williams, M. E. Cyclin D1 (PRAD1, CCND1) and glutathione S-transferase π gene expression in head and neck squamous cell carcinoma. Hum. Pathol., 26: 1221-1226, 1995.
33. Bradford, C. R., Zhu, S., Wolf, G. T., Poore, J., Fisher, S. G., Beals, T , McClatchey, K D , and Carey, T E. Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group. Otolaryngol. Head. Neck. Surg., 113: 408-412, 1995.
34. Boyle, J. O., Hakim, J., Koch, W., van der Riet, P., Hruban, R. H., Roa, R. A., Correo, R., Eby, Y. J., Ruppert, J. M., and Sidransky, D. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer. Res., 55: 4477-4480, 1993.
35. Gregg, C. M., Beals, T. E., McClatchy, K. M , Fisher, S. G., and Wolf, G. T. DNA content and tumor response to induction chemotherapy in patients with advanced laryngeal squamous cell carcinoma. Otolaryngol. Head. Neck. Surg., 108: 731-737, 1993
36. Corvo, R., Giaretti, W., Sanguineti, G , Geido, E., Orecchia, R., Guenzi, M., Margarino, G., Bacigalupo, A., Garaventa, G., Barbieri, M., and Vitale, V In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen J Clin. Oncol., 13: 1843-1850, 1995.
37. Fuqua, S. A., Oesterreich, S., Hilsenbeck, S. G., Von Hoff, D. D., Eckardt, J., and Osborne, C. K Heat shock proteins and drug resistance. Breast Cancer Res. Treat., 32: 67-71, 1994.
38. Kimura, E., Enns, R. E., Alcaraz, J. E , Arboleda, J., Slamon, D. J., and Howell, S. B. Correlation of the survival of ovarian cancer patients with mRNA expression of the 60 kD heat-shock protein HSP-60. J. Clin. Oncol, 11: 891-898, 1993.
39. Los, G., Weisman, R., Weiner, D., Benbatoul, K., van Veelen, L , Barton, R., de las Alas, M., Christen, R., Kirmani, S., Orloff, L., Robbins, K. T., and Howell, S. B. Identification of molecular markers reflecting the extent of injury induced in human tumors following treatment with chemotherapeutic agents. Proc. Am. Assoc. Cancer Res., 37: 135-136, 1996.